LEAWOOD, Kan., Nov. 28, 2017 /PRNewswire/ -- Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative therapeutics for dogs and cats, today announced that it has terminated the offering of shares of its common stock that was announced on Monday, November 27, 2017. The company believes that current market conditions are not conducive for an offering on terms that would be in the best interests of its stockholders.

Contacts 
For investor inquires:
Craig Tooman
ctooman@aratana.com  
(913) 353-1026

For media inquiries: 
Rachel Reiff
rreiff@aratana.com  
(913) 353-1050

SOURCE Aratana Therapeutics, Inc.